Date of
Transplant
|
Diagnosis
|
Donor
|
Transplant Medical Facility
|
Recipient Age (yrs)
|
Time Stored (months)
|
Collection Volume (mL)
|
Nucleated
Cell Count (x108)
|
Total CD34+ Cells (x106)
|
|
02/13
|
Chronic Myeloid Leukemia |
Allogeneic (sibling)
|
Children's Hospital Boston
|
15
|
58
|
108
|
5.90
|
1.5
|
|
11/12
|
Childhood Apraxia of Speech |
Autologous (self)
|
Duke University Medical Center, Durham, NC
|
6
|
71
|
85
|
11.90
|
9.45
|
|
9/12
|
Static Encephalopathy
|
Autologous (self)
|
Duke University Medical Center, Durham, NC
|
4
|
56
|
109
|
7.25
|
4.34
|
|
2/12
|
Cerebral Palsy
|
Autologous (self)
|
Duke University Medical Center, Durham, NC
|
3
|
18
|
79
|
4.43
|
0.43
|
|
8/11
|
Thalassemia Major
|
Allogeneic (sibling)
|
Sri Ganga Ram Hospital Rajinder Nagar, New Delhi, India
|
5
|
14
|
96
|
5.56
|
0.52
|
|
8/11
|
Thalassemia Major
|
Allogeneic (sibling)
|
BL Kapur Memorial Hospital, Pusa Road, New Delhi, India
|
7
|
16
|
131
|
0.01
|
2.07
|
|
3/11
|
Cerebral Palsy
|
Autologous (self)
|
Duke University Medical Center, Durham, NC
|
1
|
14
|
111
|
7.03
|
0.41
|
|
2/11
|
Cerebral Hypoxia
|
Autologous (self)
|
Duke University Medical Center, Durham, NC
|
3
|
41
|
63
|
5.17
|
1.02
|
|
1/11
|
Thalassemia Major
|
Allogeneic (sibling)
|
Apollo Specialty Hospital, Chennai, India
|
9
|
25
|
59
|
2.52
|
0.32
|
|
1/10
|
Thalassemia Major
|
Allogeneic (sibling)
|
Apollo Specialty Hospital, Chennai, India
|
7
|
11
|
138
|
0.01
|
3.37
|
|
11/10
|
Thalassemia Major
|
Allogeneic (sibling)
|
Apollo Specialty Hospital, Chennai, India
|
3
|
9
|
103
|
0.65
|
1.24
|
|
6/10
|
Cerebral Palsy
|
Autologous (self)
|
Duke University Medical Center, Durham, NC
|
5
|
60
|
88
|
3.78
|
0.40
|
|
6/10
|
Thalassemia Major
|
Allogeneic (sibling)
|
BL Kapur Memorial Hospital New Delhi, India
|
2
|
30
|
114
|
7.95
|
0.93
|
|
6/10
|
Cerebral Palsy
|
Autologous (self)
|
Duke University Medical Center, Durham, NC
|
1
|
17
|
95
|
2.11
|
0.64
|
|
5/10
|
Congenital Dyserythropoietic Anemia Type II
|
Allogeneic (sibling)
|
University of Michigan, Ann Arbor, MI
|
2
|
28
|
65
|
1.87
|
0.56
|
|
3/10
|
Thalassemia Major
|
Allogeneic (sibling)
|
Apollo Specialty Hospital, Chennai, India
|
4
|
40
|
85
|
0.25
|
2.44
|
|
3/10
|
Cerebral Palsy
|
Autologous (self)
|
Duke University Medical Center, Durham, NC
|
7
|
89
|
71
|
2.33
|
1.69
|
|
12/09
|
Thalassemia Major
|
Allogeneic (sibling)
|
Apollo Specialty Hospital, Chennai, India
|
2
|
13
|
128
|
9.45
|
2.91
|
|
12/09
|
Cerebral Palsy
|
Autologous (self)
|
Duke University Medical Center, Durham, NC
|
5
|
54
|
90
|
2.67
|
1.79
|
|
12/09
|
Cerebral Hypoxia
|
Autologous (self)
|
Duke University Medical Center, Durham, NC
|
2
|
24
|
88
|
2.23
|
2.09
|
|
9/09
|
Thalassemia Major
|
Allogeneic (sibling)
|
Apollo Specialty Hospital, Chennai, India
|
9
|
22
|
60
|
2.48
|
0.38
|
|
8/09
|
Cerebral Palsy
|
Autologous (self)
|
Duke University Medical Center, Durham, NC
|
6
|
80
|
72
|
2.56
|
3.08
|
|
7/09
|
Cerebral Palsy
|
Autologous (self)
|
Duke University Medical Center, Durham, NC
|
2
|
24
|
116
|
22.23
|
15.12
|
|
5/09
|
Cerebral Hypoxia
|
Autologous (self)
|
Hospital Universitario de Monterrey, Mexico
|
6
|
72
|
73
|
1.27
|
0.92
|
|
5/09
|
Cerebral Palsy
|
Autologous (self)
|
Duke University Medical Center, Durham, NC
|
5
|
75
|
96
|
4.07
|
0.84
|
|
4/09
|
Cerebral Palsy
|
Autologous (self)
|
Duke University Medical Center, Durham, NC
|
5
|
71
|
145
|
4.88
|
4.02
|
|
4/09
|
Cerebral Palsy
|
Autologous (self)
|
Duke University Medical Center, Durham, NC
|
3
|
39
|
92
|
6.57
|
2.46
|
|
3/09
|
Thalassemia Major
|
Allogeneic (sibling)
|
Apollo Specialty Hospital, Chennai, India
|
8
|
10
|
91
|
7.05
|
1.33
|
|
3/09
|
Cerebral Palsy
|
Autologous (self)
|
Duke University Medical Center, Durham, NC
|
8
|
97
|
155
|
8.73
|
8.12
|
|
1/09
|
Acute Lymphoblastic Leukemia
|
Allogeneic (sibling)
|
Duke University Medical Center, Durham, NC
|
1
|
17
|
85
|
6.01
|
0.53
|
|
12/08
|
Cerebral Palsy
|
Autologous (self)
|
Duke University Medical Center, Durham, NC
|
5
|
70
|
95
|
6.54
|
3.89
|
|
11/08
|
Cerebral Palsy
|
Autologous (self)
|
Duke University Medical Center, Durham, NC
|
6
|
78
|
130
|
2.05
|
1.41
|
|
10/08
|
Cerebral Palsy
|
Autologous (self)
|
Duke University Medical Center, Durham, NC
|
7
|
93
|
115
|
4.06
|
3.15
|
|
9/08
|
Cerebral Palsy
|
Autologous (self)
|
Duke University Medical Center, Durham, NC
|
11 mos.
|
9
|
60
|
1.72
|
1.05
|
|
8/08
|
Chronic Myeloid Leukemia
|
Allogeneic (sibling)
|
Apollo Specialty Hospital, Chennai, India
|
3
|
4
|
78
|
1.78
|
0.24
|
|
8/08
|
Sickle Cell Anemia
|
Allogeneic (sibling)
|
North Shore Long Island Jewish Children’s Hospital
|
2
|
31
|
91
|
3.36
|
1.01
|
|
6/08
|
Aplastic Anemia
|
Allogeneic (sibling)
|
Clinica Ruiz Arguelles , Puebla, Mexico
|
2
|
2
|
108
|
4.03
|
1.02
|
|
6/08
|
Cerebral Palsy
|
Autologous (self)
|
Duke University Medical Center, Durham, NC
|
6
|
79
|
100
|
4.46
|
2.93
|
|
6/08
|
Cerebral Palsy
|
Autologous (self)
|
Duke University Medical Center, Durham, NC
|
8 mos.
|
7
|
147
|
11.29
|
3.97
|
|
1/08
|
Myeloblastic Acute Leukemia M2
|
Allogeneic (sibling)
|
Juan I. Menchaca, Nuevo Hospital Civil de Guadalajara, Jalisco, Mexico
|
6
|
6
|
127
|
6.06
|
7.35
|
|
12/07
|
Neuroblastoma
|
Autologous (self)
|
Medical City Children’s Hospital, Dallas, TX
|
2
|
28
|
117
|
9.59
|
0.78
|
|
11/07
|
Type 1 Diabetes
|
Autologous (self)
|
Shands Hospital, Gainesville, FL
|
5
|
40
|
62
|
2.70
|
4.14
|
|
10/07
|
Thalassemia Major
|
Allogeneic (sibling)
|
Apollo Specialty Hospital, Chennai, India
|
4
|
17
|
115
|
2.96
|
4.96
|
|
5/07
|
Thalassemia Major
|
Allogeneic (sibling)
|
Mount Elisabeth Hospital, Singapore
|
3
|
16
|
85
|
1.29
|
9.15
|
|
4/07
|
Thalassemia Major
|
Allogeneic (sibling)
|
Steriling Hospital, Ahmedabad, India
|
7
|
21
|
75
|
3.65
|
0.13
|
|
3/07
|
Sepsis following liver transplant
|
Autologous (self)
|
(VCU) Virginia College Univeristy Medical Center, Richmond, VA
|
7
|
89
|
141
|
2.75
|
N/D
|
|
1/07
|
Ischemic Brain Injury
|
Autologous (self)
|
Duke University Medical Center, Durham, NC
|
5
|
60
|
70
|
1.27
|
1.13
|
|
9/06
|
Thalassemia Major
|
Allogeneic (sibling)
|
Siriraj Hospital, Bangkok, Thailand
|
3
|
5
|
90
|
2.79
|
0.14
|
|
9/06
|
Cerebral Palsy
|
Autologous (self)
|
Duke University Medical Center, Durham, NC
|
3
|
49
|
100
|
4.66
|
1.16
|
|
6/06
|
Asphyxia by semi-drowning
|
Autologous (self)
|
Centro de Especialidades Medicas Xalapa, Veracruz, Mexico
|
1
|
12
|
54
|
1.78
|
0.98
|
|
6/06
|
Lymphoblastic Acute Leukemia in second remission
|
Allogeneic (sibling)
|
Hospital ISSSTE, Ciudad de Mexico, Mexico
|
4
|
4
|
127
|
7.18
|
3.54
|
|
5/06
|
Type 1 Diabetes
|
Autologous (self)
|
Shands Hospital, Gainesville, FL
|
5
|
61
|
140
|
5.90
|
2.67
|
|
4/06
|
Cerebral Palsy
|
Autologous (self)
|
Duke University Medical Center, Durham, NC
|
5
|
60
|
75
|
1.90
|
1.78
|
|
1/06
|
Neuroblastoma
|
Autologous (self)
|
Vanderbilt University Medical Center, Nashville, TN
|
4
|
47
|
80
|
2.47
|
3.64
|
|
10/05
|
Acute Myeloid Leukemia
|
Allogeneic (sibling)
|
Apollo Specialty Hospital, Chennai, India
|
5
|
5
|
75
|
2.51
|
10.50
|
|
8/05
|
Type 1 Diabetes
|
Autologous (self)
|
Shands Hospital, Gainesville, FL
|
5
|
75
|
65
|
75.60
|
N/D
|
|
8/05
|
Anoxic Brain Injury/
Angelman’s Disorder
|
Autologous (self)
|
Duke University Medical Center, Durham, NC
|
2
|
37
|
120
|
3.40
|
2.72
|
|
11/04
|
Sanfilippo Syndrome
|
Allogeneic (sibling)
|
University Medical Center, Tucson, AZ
|
4
|
27
|
118
|
5.23
|
3.72
|
|
1/03
|
Acute Lymphoblastic Leukemia
|
Allogeneic (sibling)
|
University of Michigan, Ann Arbor, MI
|
5
|
7
|
65
|
1.35
|
1.57
|
|
8/02
|
Aplastic Anemia
|
Autologous (self)
|
Cedars-Sinai Medical Center, Los Angeles, CA
|
1
|
16
|
123
|
2.52
|
0.35
|
|
4/02
|
T-Cell Lymphoma
|
Allogeneic (sibling)
|
All Children’s Hospital, St. Petersburg, FL
|
4
|
2
|
145
|
4.84
|
5.31
|